Rheumatoid arthritis is a long-term disease that affects millions of people around the world. It happens when the body’s immune system mistakenly attacks healthy joints, causing pain, swelling, stiffness, and difficulty moving.
Over time, the disease can damage joints and affect daily life. Many people with rheumatoid arthritis take medicines that reduce inflammation and help control the immune system. For most patients, these treatments work well and help them achieve long periods with few or no symptoms.
However, doctors have long been puzzled by a group of patients whose symptoms continue even when their inflammation appears to be under control.
These people often continue to experience pain, fatigue, poor physical function, and reduced quality of life despite receiving modern treatments. Researchers have referred to these patients as having difficult-to-treat rheumatoid arthritis.
Now, researchers at Semmelweis University in Hungary have taken a closer look at why this happens. Their findings suggest that inflammation is only part of the story.
According to their research, other health problems such as depression, sleep disorders, obesity, smoking, and chronic pain may play a major role in keeping symptoms alive even when the underlying disease is being treated.
The researchers published their findings in Nature Reviews Rheumatology and The Lancet Rheumatology. Their work challenges the common assumption that ongoing symptoms automatically mean that inflammation is still active. Instead, they suggest that doctors should take a broader view of the patient’s overall health.
Rheumatoid arthritis is an autoimmune disease, meaning the immune system attacks the body’s own tissues. The disease mainly affects the joints, but it can also influence other parts of the body.
Symptoms often include pain, swelling, stiffness, tiredness, and reduced mobility. Because inflammation is a key feature of the disease, treatment has traditionally focused on reducing inflammation as much as possible.
Modern treatment follows an approach called “treat-to-target.” Under this system, doctors regularly measure signs of disease activity and adjust medications if treatment goals are not reached. This strategy has greatly improved outcomes for many patients. Yet some patients continue to struggle even when tests show that inflammation has decreased.
The Semmelweis University team found that several other conditions may help explain this problem. For example, a person with rheumatoid arthritis may also suffer from depression. Depression can reduce motivation to exercise, lower energy levels, worsen sleep quality, and increase feelings of pain.
Poor sleep may then make pain feel worse the next day. Reduced activity can lead to weight gain, and obesity may place extra stress on the body. Smoking can further worsen overall health. Together, these factors can create a cycle that becomes difficult to escape.
The researchers describe this as a vicious cycle in which multiple problems reinforce one another. Pain contributes to depression, depression affects sleep, poor sleep worsens pain, and weight gain adds further strain. Over time, the patient’s symptoms may continue even when inflammation is no longer the main problem.
To address this challenge, the researchers developed a new model to help doctors identify the true causes of persistent symptoms. Rather than simply increasing medication whenever a patient reports pain or fatigue, doctors can look more carefully at other factors that may be contributing.
Dr. György Nagy, head of the Department of Rheumatology and Immunology at Semmelweis University, explained that when test results improve but patients still feel unwell, doctors should pause and investigate further. In some cases, chronic pain conditions, depression, sleep disorders, or obesity may be playing a larger role than inflammation itself.
According to the researchers, using this broader approach can improve treatment outcomes and strengthen the relationship between doctors and patients. Patients may feel more understood when their symptoms are examined from multiple angles rather than being attributed solely to joint inflammation.
The research has gained significant international attention. The publications introducing the concept of difficult-to-treat rheumatoid arthritis and the related treatment approach have been cited more than one thousand times by other researchers.
The definition developed by the team is now being used worldwide and has influenced thinking about other chronic diseases as well.
The researchers are also looking ahead. They plan to participate in projects that use artificial intelligence to identify patterns among patients. By analyzing large amounts of data, AI could help doctors identify different patient groups and develop treatment plans that are tailored to individual needs.
The findings highlight an important message: managing rheumatoid arthritis is not only about controlling inflammation. Mental health, sleep quality, body weight, smoking habits, and chronic pain may all influence how patients feel and function.
A more complete understanding of these factors could help many people who continue to struggle despite receiving appropriate treatment.
The study’s strength is that it looks at the whole patient rather than focusing only on inflammation. This reflects the reality that chronic diseases are often influenced by many interconnected factors. One limitation is that the proposed model still requires further testing in real-world healthcare settings.
Future studies, especially those using artificial intelligence, may help confirm which strategies work best. Overall, the research offers a practical and promising new way to improve care for people with difficult-to-treat rheumatoid arthritis.
Source: Semmelweis University.
